Multitarget Derivatives of D2AAK1 as Potential Antipsychotics: The Effect of Substitution in the Indole Moiety

Schizophrenia is a complex disease which is best treated with multitarget drugs, such as atypical antipsychotics. Previously, using structure-based virtual screening, we found a virtual hit, D2AAK1, with nanomolar affinity for dopamine and serotonin receptors important in schizophrenia pharmacothera...

Descripción completa

Detalles Bibliográficos
Autores: Kondej, Magda, Wróbel, Tomasz M., Targowska-Duda, Katarzyna M., Martínez Rodríguez, Antón Leandro, Koszła, Oliwia, Stępnicki, Piotr, Zięba, Agata, Paz, Alba, Wronikowska-Denysiuk, Olga, Loza García, María Isabel, Castro Pérez, María de los Ángeles, Kaczor, Agnieszka A.
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universidad de Santiago de Compostela (USC)
Repositorio:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Idioma:inglés
OAI Identifier:oai:minerva.usc.gal:10347/39461
Acceso en línea:https://hdl.handle.net/10347/39461
Access Level:acceso abierto
Palabra clave:Antipsychotics
Behavioral studies
G protein-coupled receptors
Multitarget drugs
Schizophrenia
3209 Farmacología
2390 Química farmacéutica
Descripción
Sumario:Schizophrenia is a complex disease which is best treated with multitarget drugs, such as atypical antipsychotics. Previously, using structure-based virtual screening, we found a virtual hit, D2AAK1, with nanomolar affinity for dopamine and serotonin receptors important in schizophrenia pharmacotherapy. As a part of an optimization campaign of D2AAK1, we obtained 17 derivatives that also display a multitarget profile. Selected compounds were tested against off-targets in schizophrenia, i. e., histamine H1 receptor and muscarinic M1 receptor, and these did not display considerable affinity for these receptors. The two most promising compounds were subjected to behavioral studies. These compounds decreased amphetamine-induced hyperactivity in mice which indicates their antipsychotic potential. The compounds did not interfere with the memory consolidation in mice, as determined in the passive avoidance test. The favorable pharmacological profile of these compounds was rationalized using molecular modeling.